Radiance's new catheter designs in BRITE trials:
This article was originally published in Clinica
Radiance Medical Systems has gained permission from the US FDA to use new catheter designs of its monorail RDX coronary radiation delivery system in its BRITE II and BRITE-SVG in-stent restenosis studies (see Clinica No 942, p 22). The Irvine, California company says it has enhanced the materials and design features of the RDX to provide a lower profile, more flexible device, with a longer shelf-life. An over-the-wire version of the RDX catheter has also been approved for use in both trials.